Ping Shi

No ORCID on file · 2 papers in corpus

other 2024

Identification of Hydroxysteroid Dehydrogenase Type 1 As a Potential Bladder Tumor Marker

Iranian biomedical journal ·doi:10.61186/ibj.4068

BACKGROUND: The 17beta-hydroxysteroid dehydrogenase type 1 (HSD17B) family has been implicated in the prognosis and treatment prediction of various malignancies; however, its association with bladder cancer (BLCA) remains unclear. This stud…

rct 2022

Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone antagonist in healthy premenopausal women

Frontiers in pharmacology ·doi:10.3389/fphar.2022.1027648

Background: Treatment with gonadotropin-releasing hormone (GnRH) antagonists is a powerful strategy to suppress gonadotropin activity in women with sex hormone-dependent disorders. Herein, we provide the safety, pharmacokinetics (PK), and p…